Additionally, both IL8 and CXCL2 upregulation was observed in vitro after exposing glioma cells to TMZ, which suggests a potential role of the CXCR2 signaling pathway in the development of resistance against TMZ [31]. The gene discussed is CXCR2; the disease is glioma.